Compare Stocks: MLSS, FOCL, HSAQ, and KRMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$155.74M	-0.07	78,728 shs	104,833 shs
HSAQ Health Sciences Acquisitions Co. 2	$6.08 +5.2%	$4.66	$9.41 ▼ $13.80	$68.17M	0.09	205,918 shs	1.14 million shs
KRMD KORU Medical Systems	$3.23 +0.3%	$3.56	$3.06 ▼ $6.61	$148.36M	0.43	173,153 shs	676,652 shs
MLSS Milestone Scientific	$0.41 -4.0%	$0.45	$0.22 ▼ $0.60	$36.94M	1.08	859,782 shs	98,321 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	0.00%	+1.22%	-2.12%	-13.72%	+414,999,900.00%
HSAQ Health Sciences Acquisitions Co. 2	+5.19%	-0.65%	+9.55%	+52.38%	+140.32%
KRMD KORU Medical Systems	0.00%	+2.22%	-1.22%	-17.18%	-18.43%
MLSS Milestone Scientific	0.00%	-8.22%	-13.35%	+9.75%	-26.03%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$155.74M	-0.07	78,728 shs	104,833 shs
HSAQ Health Sciences Acquisitions Co. 2	$6.08 +5.2%	$4.66	$9.41 ▼ $13.80	$68.17M	0.09	205,918 shs	1.14 million shs
KRMD KORU Medical Systems	$3.23 +0.3%	$3.56	$3.06 ▼ $6.61	$148.36M	0.43	173,153 shs	676,652 shs
MLSS Milestone Scientific	$0.41 -4.0%	$0.45	$0.22 ▼ $0.60	$36.94M	1.08	859,782 shs	98,321 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	0.00%	+1.22%	-2.12%	-13.72%	+414,999,900.00%
HSAQ Health Sciences Acquisitions Co. 2	+5.19%	-0.65%	+9.55%	+52.38%	+140.32%
KRMD KORU Medical Systems	0.00%	+2.22%	-1.22%	-17.18%	-18.43%
MLSS Milestone Scientific	0.00%	-8.22%	-13.35%	+9.75%	-26.03%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FOCL FocalTherics	2.40	Hold	$7.75	86.75% Upside
HSAQ Health Sciences Acquisitions Co. 2	0.00	N/A	N/A	N/A
KRMD KORU Medical Systems	2.60	Moderate Buy	$7.00	116.72% Upside
MLSS Milestone Scientific	3.00	Buy	$1.00	145.40% Upside

Current Analyst Ratings Breakdown

Latest MLSS, FOCL, HSAQ, and KRMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/14/2026	KRMD KORU Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/25/2026	FOCL FocalTherics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/19/2026	KRMD KORU Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/17/2026	FOCL FocalTherics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	MLSS Milestone Scientific	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1.00
8/17/2026	MLSS Milestone Scientific	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Speculative Buy
8/14/2026	FOCL FocalTherics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$4.00
8/6/2026	KRMD KORU Medical Systems	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
7/30/2026	KRMD KORU Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$15.00
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FOCL FocalTherics	$70.53M	2.21	N/A	N/A	$0.52 per share	7.98
HSAQ Health Sciences Acquisitions Co. 2	N/A	N/A	N/A	N/A	($0.62) per share	N/A
KRMD KORU Medical Systems	$41.13M	3.61	N/A	N/A	$0.37 per share	8.73
MLSS Milestone Scientific	$9.42M	3.92	N/A	N/A	$0.11 per share	3.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FOCL FocalTherics	-$29.25M	-$1.03	N/A	N/A	N/A	-56.26%	-248.00%	-44.69%	N/A
HSAQ Health Sciences Acquisitions Co. 2	-$380K	N/A	N/A	N/A	N/A	N/A	N/A	-2.38%	N/A
KRMD KORU Medical Systems	-$2.64M	-$0.04	N/A	64.60	N/A	-4.03%	-10.63%	-6.51%	11/11/2026 (Estimated)
MLSS Milestone Scientific	-$6.93M	-$0.04	N/A	N/A	N/A	-52.01%	-60.26%	-40.23%	N/A

Latest MLSS, FOCL, HSAQ, and KRMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2026	Q2 2026	FOCL FocalTherics	-$0.20	-$0.39	-$0.19	-$0.39	N/A	$13.20 million
8/5/2026	Q2 2026	KRMD KORU Medical Systems	-$0.0180	$0.01	+$0.0280	$0.01	$11.62 million	$12.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
HSAQ Health Sciences Acquisitions Co. 2	N/A	N/A	N/A	N/A	N/A
KRMD KORU Medical Systems	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FOCL FocalTherics	1.79	1.60	1.38
HSAQ Health Sciences Acquisitions Co. 2	N/A	0.17	0.61
KRMD KORU Medical Systems	N/A	2.72	2.09
MLSS Milestone Scientific	N/A	2.85	1.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FOCL FocalTherics	62.74%
HSAQ Health Sciences Acquisitions Co. 2	89.71%
KRMD KORU Medical Systems	58.60%
MLSS Milestone Scientific	5.79%

Insider Ownership

Company	Insider Ownership
FOCL FocalTherics	10.10%
HSAQ Health Sciences Acquisitions Co. 2	21.90%
KRMD KORU Medical Systems	18.50%
MLSS Milestone Scientific	9.22%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FOCL FocalTherics	230	37.53 million	33.74 million	N/A
HSAQ Health Sciences Acquisitions Co. 2	4	11.21 million	8.76 million	Not Optionable
KRMD KORU Medical Systems	73	45.93 million	37.44 million	Optionable
MLSS Milestone Scientific	15	90.64 million	58.61 million	Optionable

MLSS, FOCL, HSAQ, and KRMD Headlines

Recent News About These Companies

Milestone Scientific Partners With Pain And Spine Specialists On CompuFlo Development; Stock Up

September 16, 2026 | rttnews.com

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

September 16, 2026 | globenewswire.com

Milestone Scientific Earnings Call Highlights CompuFlo Surge

August 29, 2026 | theglobeandmail.com

Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

August 26, 2026 | markets.businessinsider.com

Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

Milestone Scientific Reports Financial Results for Second Quarter 2026

August 14, 2026 | globenewswire.com

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

August 6, 2026 | globenewswire.com

Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

August 4, 2026 | globenewswire.com

Milestone Scientific Directors Elect Conversion of Bridge Notes

July 29, 2026 | tipranks.com

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

July 15, 2026 | globenewswire.com

Milestone Scientific Corporate Event Calendar | AMEX:MLSS

July 12, 2026 | benzinga.com

Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

July 1, 2026 | globenewswire.com

Milestone Scientific Strengthens Board to Support Next Phase of Growth

June 25, 2026 | globenewswire.com

Milestone Scientific Inc. Reports Increased Adoption of CompuFlo® Epidural System Following Positive Research Findings from University of Texas Medical Branch

May 27, 2026 | quiverquant.comQ

Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

May 27, 2026 | globenewswire.com

Analysts Are Bullish on These Healthcare Stocks: Milestone Scientific (MLSS), Inhibikase Therapeutics (IKT)

May 17, 2026 | theglobeandmail.com

Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...

May 16, 2026 | finance.yahoo.com

Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript

May 14, 2026 | seekingalpha.com

Milestone Scientific Reports Financial Results for First Quarter 2026

May 14, 2026 | globenewswire.com

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

May 7, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS, FOCL, HSAQ, and KRMD Company Descriptions

FocalTherics NASDAQ:FOCL

$4.15 -0.13 (-3.04%)

As of 09/18/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

$6.08 +0.30 (+5.19%)

As of 09/18/2026

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

KORU Medical Systems NASDAQ:KRMD

$3.23 +0.01 (+0.31%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$3.13 -0.10 (-3.07%)

As of 09/18/2026 07:55 PM Eastern

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Milestone Scientific NYSE:MLSS

$0.41 -0.02 (-3.96%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.43 +0.02 (+5.77%)

As of 09/18/2026 08:00 PM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MLSS, FOCL, HSAQ, and KRMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MLSS, FOCL, HSAQ, and KRMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MLSS, FOCL, HSAQ, and KRMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS, FOCL, HSAQ, and KRMD Company Descriptions

FocalTherics NASDAQ:FOCL

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

KORU Medical Systems NASDAQ:KRMD

Milestone Scientific NYSE:MLSS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MLSS, FOCL, HSAQ, and KRMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MLSS, FOCL, HSAQ, and KRMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MLSS, FOCL, HSAQ, and KRMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS, FOCL, HSAQ, and KRMD Company Descriptions

FocalTherics NASDAQ:FOCL

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

KORU Medical Systems NASDAQ:KRMD

Milestone Scientific NYSE:MLSS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools